Literature DB >> 17147925

Hypertension and the expanding role of aldosterone.

Scott M Mackenzie1, John Connell.   

Abstract

Aldosterone is the principal human mineralocorticoid and plays a significant role in hypertension and cardiovascular morbidity. Classically, aldosterone is synthesized in the adrenal zona glomerulosa and binds to mineralocorticoid receptors in the cytosol of target epithelial cells. Nonepithelial and rapid nongenomic actions of aldosterone have now also been described, as well as a number of extra-adrenal sites of synthesis, including the central nervous system. Recent studies also suggest that elevated aldosterone biosynthesis, as defined by an increased aldosterone-to-renin ratio, is present in up to 15% of essential hypertensives and that aldosterone levels predict the development of hypertension in normotensive individuals. Furthermore, mineralocorticoid-receptor antagonists demonstrate that aldosterone is a significant contributor to cardiovascular pathology. In this article, we present the evidence behind these findings and explore the expanding role of aldosterone as a key cardiovascular hormone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17147925     DOI: 10.1007/s11906-006-0059-y

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  54 in total

1.  A hybrid cell mapping panel for regional localization of probes to human chromosome 8.

Authors:  M J Wagner; Y Ge; M Siciliano; D E Wells
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

2.  Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor.

Authors:  Chun Xue; Helmy M Siragy
Journal:  Hypertension       Date:  2005-07-25       Impact factor: 10.190

3.  An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone system.

Authors:  I Komiya; T Yamada; N Takasu; T Asawa; H Akamine; N Yagi; Y Nagasawa; H Ohtsuka; Y Miyahara; H Sakai; A Sato; T Aizawa
Journal:  J Hypertens       Date:  1997-01       Impact factor: 4.844

4.  Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation.

Authors:  J S Silvestre; V Robert; C Heymes; B Aupetit-Faisant; C Mouas; J M Moalic; B Swynghedauw; C Delcayre
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

5.  Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome).

Authors:  G C Inglis; P F Plouin; E C Friel; E Davies; R Fraser; J M Connell
Journal:  Clin Endocrinol (Oxf)       Date:  2001-06       Impact factor: 3.478

6.  Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.

Authors:  C E Fardella; L Mosso; C Gómez-Sánchez; P Cortés; J Soto; L Gómez; M Pinto; A Huete; E Oestreicher; A Foradori; J Montero
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

7.  CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism.

Authors:  P Mulatero; D Schiavone; F Fallo; F Rabbia; C Pilon; L Chiandussi; L Pascoe; F Veglio
Journal:  Hypertension       Date:  2000-03       Impact factor: 10.190

8.  Aldosterone blunts the baroreflex response in man.

Authors:  K M Yee; A D Struthers
Journal:  Clin Sci (Lond)       Date:  1998-12       Impact factor: 6.124

9.  A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.

Authors:  R P Lifton; R G Dluhy; M Powers; G M Rich; S Cook; S Ulick; J M Lalouel
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

10.  Immunochemical detection of the mineralocorticoid receptor in rat brain.

Authors:  M K Agarwal; F Mirshahi; M Mirshahi; W Rostene
Journal:  Neuroendocrinology       Date:  1993-11       Impact factor: 4.914

View more
  3 in total

1.  Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone.

Authors:  Joseph C K Leung; Loretta Y Y Chan; Sydney C W Tang; Man-Fai Lam; Chui-Wa Chow; Ai-Ing Lim; Kar-Neng Lai
Journal:  J Transl Med       Date:  2011-10-06       Impact factor: 5.531

2.  Cooperative Oxygen Sensing by the Kidney and Carotid Body in Blood Pressure Control.

Authors:  Daniela Patinha; Wioletta Pijacka; Julian F R Paton; Maarten P Koeners
Journal:  Front Physiol       Date:  2017-10-04       Impact factor: 4.566

Review 3.  Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.

Authors:  Juan Carlos Yugar-Toledo; Rodrigo Modolo; Ana Paula de Faria; Heitor Moreno
Journal:  Vasc Health Risk Manag       Date:  2017-10-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.